HIGHLIGHTS
- who: Meng Zhang and colleagues from the DepartmentJiaotong University, Xi`an, China have published the research work: Authorship note: MZ, KKLC, and ZYC are co-first authors. GJK, BYS, and YW are co-senior authors. Conflict of interest: The authors have declared that no conflict of interest exists, in the Journal: (JOURNAL) of March/21,/2022
- what: The authors propose that CD4+ CTLs are a potentially novel target for inflammation, cytotoxicity, and fibrosis in GO. In this study, using several in_vitro and in_vivo models, the authors have demonstrated that rapamycin suppresses the upregulated mTOR pathways . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.